|
Ribera JM, Morgades M, Montesinos P, Tormo M, Martinez-Carballeira D, Gonzalez-Campos J, Gil C, Barba P, Garcia-Boyero R, Coll R, Pedreno M, Ribera J, Mercadal S, Vives S, Novo A, Genesca E, Hernandez-Rivas JM, Bergua J, Amigo ML, Vall-Llovera F, Martinez-Sanchez P, Calbacho M, Garcia-Cadenas I, Garcia-Guinon A, Sanchez-Sanchez MJ, Cervera M, Feliu E, Orfao A; PETHEMA Group, Spanish Society of Hematology. A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial. Cancer Med. 2020 Apr;9(7):2317-2329. doi: 10.1002/cam4.2814. Epub 2020 Feb 5. PubMed PMID: 32022463; PubMed Central PMCID: PMC7131850.
AÑO: 2020; IF: 4.452
|
32022463
|
Bravo-Perez C, Pajares I, Muina B, Escobar H, Amigo ML, Garcia-Malo MD, Garcia J, Rodriguez-Pinilla SM, Piris MA, Ortuno FJ. Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma. Ann Hematol. 2020 Feb;99(2):391-393. doi: 10.1007/s00277-019-03897-3. Epub 2019 Dec 20. No abstract available. PubMed PMID: 31858188.
AÑO: 2020; IF: 3.673
|
|
Martinez-Cuadron D, Serrano J, Mariz J, Gil C, Tormo M, Martinez-Sanchez P, Rodriguez-Arboli E, Garcia-Boyero R, Rodriguez-Medina C, Martinez-Chamorro C, Polo M, Bergua J, Aguiar E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Espadana A, Sayas MJ, Algarra L, Vidriales MB, Vasconcelos G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Chillon MC, Rodriguez-Gutierrez JI, Calasanz MJ, Labrador J, Lopez JA, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Barragan E, Sanz MA, Montesinos P, On Behalf Of The Pethema Group. Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia. Cancers (Basel). 2022 Jun 6;14(11):2817. doi: 10.3390/cancers14112817. PubMed PMID: 35681796; PubMed Central PMCID: PMC9179309.
AÑO: 2022; IF: 6.575
|
|
Labrador J, Martinez-Cuadron D, Boluda B, Serrano J, Gil C, Perez-Simon JA, Bernal T, Bergua JM, Martinez-Lopez J, Rodriguez-Medina C, Vidriales MB, Garcia-Boyero R, Algarra L, Polo M, Sayas MJ, Tormo M, Alonso-Dominguez JM, Herrera P, Lavilla E, Ramos F, Amigo ML, Vives-Polo S, Rodriguez-Macias G, Mena-Duran A, Perez-Encinas MM, Arce-Fernandez O, Cuello R, Sanchez-Garcia J, Gomez-Casares MT, Chillon MC, Calasanz MJ, Ayala R, Rodriguez-Veiga R, Barragan E, Montesinos P; PETHEMA Group. Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry. Cancer. 2024 Oct 15;130(20):3436-3451. doi: 10.1002/cncr.35431. Epub 2024 Jun 19. PubMed PMID: 38896056.
AÑO: 2024; IF: 6.1
|
|
Suarez EU, Boluda B, Lavilla E, Tormo M, Botella C, Gil C, Vives S, Rodriguez C, Serrano J, Sayas MJ, Martinez-Sanchez P, Ramos F, Bernal T, Algarra L, Bergua-Burgues JM, Perez-Simon JA, Herrera P, Barrios M, Noriega-Concepcion V, Raposo-Puglia JA, Ayala R, Barragan E, Martinez-Cuadron D, Amigo ML, Lopez-Lorenzo JL, Lazaro-Garcia A, Guimaraes JE, Colorado M, Garcia-Boyero R, De Rueda-Ciller B, Foncillas-Garcia M, Hong A, Labrador J, Alonso-Dominguez JM, Montesinos P; PETHEMA group. Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens? Ann Hematol. 2024 Aug;103(8):2845-2851. doi: 10.1007/s00277-024-05840-7. Epub 2024 Jun 17. PubMed PMID: 38884787.
AÑO: 2024; IF: 3.0
|